Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ironwood Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 1998 · IPO 2010 Thoroughbred

We are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients

Valuation
$1.06B
Market cap · May/2026
Revenue
$296M
Latest reported FY
EBITDA
$306M
Latest reported FY

Investors

4 investors on Ironwood Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Series B+ 3 investors entered at this stage

Global footprint

Where Ironwood Pharmaceuticals has talent and traffic

AI talent share
0.8% of workforce is AI talent
(2 of 262 staff)
Core AI10.38%
Other AI10.38%
Non-AI workforce26099.24%
Workforce by country
11 countries with
team presence
🇺🇸 United States79.3%
🇨🇭 Switzerland11.8%
🇪🇸 Spain1.6%
🇬🇧 United Kingdom1.5%
🇧🇪 Belgium1%
Top 5 of 11 shown
Web traffic by country
9.8K monthly visits
across markets
🇺🇸 United States66.3%
🇨🇦 Canada19.4%
🇮🇳 India10.2%
🇯🇵 Japan4.1%
🇨🇭 Switzerland2%
Top 5 markets shown

Market sentiment

What the market is saying about Ironwood Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Ironwood Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ironwood Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.